Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      SINGAPORE STRENGTHENS SARCOMA CARE THROUGH COORDINATED, MULTIDISCIPLINARY APPROACH

      (PRNewsfoto/National University Health System (NUHS))

      News provided by

      National University Cancer Institute, Singapore (NCIS)

      Apr 11, 2026, 04:20 ET

      Share this article

      Share this article


      NCIS leads multi-institutional effort to develop expert multidisciplinary guidance to improve sarcoma diagnosis, referrals and outcomes

      SINGAPORE, April 11, 2026 /PRNewswire/ -- Singapore is strengthening its approach to sarcoma care, a rare group of bone and soft tissue cancers that disproportionately affect adolescents and young adults, through closer coordination across specialties and institutions, enhanced clinical guidance, and continued investment in multidisciplinary care.

      Continue Reading
      Adjunct Associate Professor Chee Cheng Ean (leftmost), Executive Director of the National University Cancer Institute, Singapore (NCIS), and Professor Lim Soon Thye (rightmost), Chief Executive Officer of the National Cancer Centre Singapore, with the editors of Clinical Management of Bone and Soft Tissue Tumors at the book launch.
        From left: Dr Choo Bok Ai, Associate Professor James Hallinan, Adjunct Associate Professor Mark Edward Puhaindran, Associate Professor Victor Lee Kwan Min, and Dr Angela Pang Shien Ling.
      Adjunct Associate Professor Chee Cheng Ean (leftmost), Executive Director of the National University Cancer Institute, Singapore (NCIS), and Professor Lim Soon Thye (rightmost), Chief Executive Officer of the National Cancer Centre Singapore, with the editors of Clinical Management of Bone and Soft Tissue Tumors at the book launch. From left: Dr Choo Bok Ai, Associate Professor James Hallinan, Adjunct Associate Professor Mark Edward Puhaindran, Associate Professor Victor Lee Kwan Min, and Dr Angela Pang Shien Ling.

      Sarcoma can arise almost anywhere in the body and often presents as a painless lump, resembling benign conditions. This frequently leads to delayed referrals and late‑stage diagnosis. While sarcoma accounts for fewer than one per cent of adult cancers, it represents approximately 21 per cent of paediatric cancers[1], affecting many adolescents and young adults.

      To address these challenges, clinicians from across Singapore's healthcare system – including the National University Cancer Institute, Singapore (NCIS), National Cancer Centre Singapore (NCCS) and international contributors – have been working together to strengthen early recognition, clarify referral pathways and enhance multidisciplinary management. These efforts bring together expertise in surgery, medical oncology, radiation oncology, pathology, imaging and allied health to support better care for patients. 

      A rare cancer requiring highly complex, multidisciplinary care

      With more than 100 subtypes, each requiring different diagnostic and treatment pathways, effective sarcoma care relies heavily on specialised expertise and coordinated multidisciplinary management.

      When Mr Terence Goh was diagnosed with retroperitoneal pleomorphic sarcoma in 2023, he quickly learnt that sarcoma does not follow simple or predictable pathways, nor does its treatment. At 46, Mr Goh underwent neoadjuvant radiotherapy prior to surgery. This was followed by an exceptionally complex surgical journey involving multiple organs, prolonged operating time and intensive peri‑operative planning. His primary tumour, located deep within the retroperitoneum, required a highly complex operation involving multiple surgical teams. The surgery was prolonged and technically demanding, and he encountered significant challenges during both the peri‑operative and post‑operative periods. Radiotherapy further complicated the surgery, with surrounding tissues affected by scarring and inflammation. Subsequent developments required additional procedures, including the removal of a non‑functioning kidney compressed by the tumour.

      Throughout his treatment journey, Mr Goh has been cared for at NCIS, where his case has required repeated multidisciplinary review, escalation of therapy and long‑term follow‑up care. Mr Goh underwent a complex chemotherapy protocol, targeted therapy in close coordination with the NUH's Division of Nephrology to protect his sole kidney, and multiple surgeries involving both the chest and abdomen.

      "I'm still fighting," Mr Goh said. "What keeps me going is trusting the doctors and doing my best to live as normally as possible, for my family and for myself."

      A father of two young children, Mr Goh credits his wife and family for sustaining him through repeated hospitalisations, treatment side effects and prolonged recovery. Despite ongoing challenges, he remains deeply supportive of sarcoma research and has expressed openness for his case to contribute to advancing medical knowledge.

      "I hope more people understand sarcoma better," he said. "More research, more awareness and more treatment options can make a real difference."

      Strengthening early identification and referral

      A key challenge in sarcoma care is early identification. Many clinicians encounter sarcoma infrequently, which can lead to uncertainty in recognising suspicious features and knowing when to escalate care.

      Adjunct Professor Mark Edward Puhaindran, Chairman of the Medical Board at National University Hospital (NUH) and Senior Consultant in the Division of Surgical Oncology, NCIS, added: "In clinical practice, the rarity of sarcoma means that many doctors may see only a handful of cases in their careers, leading to uncertainty in recognising the condition, and deciding when to escalate or refer. Strengthening awareness and mapping out clearer decision pathways are therefore important steps towards improving outcomes."

      Developing expert multidisciplinary guidance

      As part of this broader effort, clinicians from Singapore and international centres have come together to develop expert multidisciplinary guidance to support the diagnosis and management of sarcoma. 

      This includes the development of a new clinical handbook, Clinical Management of Bone and Soft Tissue Tumours. The Singapore‑led effort brings together the collective expertise of 70 local and international contributors across specialties and aims to support healthcare professionals in navigating complex diagnostic pathways, identifying when specialist referral is required, and determining appropriate multimodal treatment approaches.

      Associate Professor Victor Lee Kwan Min, Head and Senior Consultant, Department of Pathology, NUH, and Senior Consultant, NCIS, a lead editor of the handbook[2] said: "Sarcoma pathology is inherently complex. These tumours are rare, highly diverse and often difficult to characterise, which means accurate diagnosis depends on specialist expertise supported by appropriate ancillary tests. We hope this handbook helps clinicians better navigate these complexities and arrive at the most appropriate treatment plan for their patients."

      Among the handbook's lead editors is Associate Professor James Hallinan, Senior Consultant, Department of Diagnostic Imaging, NUH, and Senior Consultant, Division of Musculoskeletal Oncology, Department of Diagnostic Imaging, NCIS, who said: "Imaging plays a pivotal role in the early detection and characterisation of sarcomas. The handbook outlines core principles, indications and limitations to guide clinicians on when further investigation or specialist referral is warranted. Timely and appropriate imaging can significantly influence treatment planning and outcomes."

      Developed by NCIS in partnership with institutes such as NCCS and international contributors, the handbook reflects Singapore's integrated ecosystem, which brings together orthopaedic oncology, pathology, radiology, surgery, medical oncology and allied health expertise within a single coordinated network.

      Beyond diagnosis: fighting cancer with purpose

      Mr Hilman Basri was just 29 when he first noticed a growing lump on his foot in late 2015. Initially dismissed as a minor issue, the swelling grew so large that he had to buy shoes a size bigger, but cancer was the last thing on his mind.

      A referral led him to NCIS where a biopsy confirmed a rare diagnosis: clear cell sarcoma, an uncommon and aggressive subtype of soft tissue sarcoma. Surgery followed in January 2016, including complex reconstruction and a skin graft taken from his arm.

      Although Mr Basri continues to live with persistent disease and has required further complex surgeries and ongoing medical treatment over the years, his journey has been defined not by limitation, but by determination.

      Under the care of Adjunct Professor Mark Edward Puhaindran, who is also a lead editor of the handbook, Mr Basri's management extended beyond surgery to include long‑term follow‑up, rehabilitation, and continued treatment. Encouraged by Advanced Practice Nurse Ms Foong Li Li and his care team to choose resilience over resignation, Mr Basri reframed his outlook on life. He adopted a healthier lifestyle and turned to running as a way to cope, both physically and mentally, with the demands of living with cancer.

      Since 2018, he has run the Run For Hope Marathon annually, often training and competing in between surgeries and medical treatments. Each race represents not recovery from cancer, but a powerful affirmation of what is still possible despite it.

      "This is not a death sentence," Mr Basri said. "It is not the end, but the beginning of a new chapter."

      [1] Source: Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2:14. https://doi.org/10.1186/2045-3329-2-14. 

      [2] Editors of Clinical Management of Bone and Soft Tissue Tumours: Prof Mark Edward Puhaindran, Prof Victor Lee Kwan Min, Dr Thomas Patrick Decourcy Hallinan, Dr Angela Shien, Prof Bok Ai Choo

      Chinese Glossary

      National University Cancer Institute, Singapore (NCIS)

      新加坡国立大学癌症中心

      National University Hospital (NUH)

      国立大学医院

      National Cancer Centre Singapore (NCCS)

      新加坡国立癌症中心

      Adjunct Professor Mark Edward Puhaindran

      Chairman, Medical Board, National University Hospital (NUH) &
      Senior Consultant
      Division of Surgical Oncology
      National University Cancer Institute, Singapore (NCIS)

      Mark Edward Puhaindran客座教授

      国立大学医院医疗委员会主席 &

      高级顾问医生

      肿瘤外科

      新加坡国立大学癌症中心

      Associate Professor Victor Lee Kwan Min

      Head & Senior Consultant

      Department of Pathology
      National University Hospital (NUH) &
      Senior Consultant
      National University Cancer Institute, Singapore (NCIS)

      李光明医生副教授

      主任兼高级顾问医生

      病理科

      国立大学医院(国大医院) &

      高级顾问医生
      新加坡国立大学癌症中心

      Associate Professor James Hallinan

      Senior Consultant

      Department of Diagnostic Imaging

      National University Hospital (NUH) &
      Senior Consultant
      Division of Musculoskeletal Oncology, Department of Diagnostic Imaging
      National University Cancer Institute, Singapore (NCIS)

      詹姆士•哈利南医生副教授

      高级顾问医生

      影像诊断科

      国立大学医院(国大医院) &

      高级顾问医生

      肿瘤外科 (肌肉骨骼外科),
      影像诊断科

      新加坡国立大学癌症中心

      Mr Hilman Basri

      Hilman Basri先生

      Mr Terence Goh

      吴振扬先生

      About the National University Cancer Institute, Singapore (NCIS)

      The National University Cancer Institute, Singapore (NCIS) is an academic, national specialist centre for cancer under the National University Health System (NUHS), and is the only public cancer centre in Singapore that treats both paediatric and adult cancers in one facility.

      As one of two national cancer centres in Singapore, NCIS (pronounced as "n-sis") offers a broad spectrum of cancer care and management from screening, diagnosis and treatment to rehabilitation and survivorship, as well as palliative and long-term care. NCIS' strength lies in the multi-disciplinary approach taken by our clinician scientists and clinician-investigators to develop a comprehensive and personalised plan for each cancer patient.

      NCIS provides the full suite of specialised oncology and haematology services at the NUH Medical Centre at Kent Ridge, Singapore, including those by the NCIS Chemotherapy Centre, NCIS Radiotherapy Centre and NCIS Cellular Therapy Centre.

      NCIS also offers cancer services at other hospitals in Singapore:

      • NCIS Cancer & Blood Clinic @ Ng Teng Fong General Hospital
      • NCIS Radiotherapy Centre @ Tan Tock Seng Hospital
      • NCIS Radiotherapy Clinic @ Khoo Teck Puat Hospital

      To bring cancer care even closer to our patients, our NCIS on the Go programme delivers a range of cancer services at clinics within the community for their convenience. 

      For more information, please visit www.ncis.com.sg. 

      SOURCE National University Cancer Institute, Singapore (NCIS)

      Modal title

      Also from this source

      DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS

      DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS

      Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a troubling mix of...

      More Releases From This Source

      Explore

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Medical Equipment

      Medical Equipment

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.